3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Gastrointestinal
1
Conditions
Pancreatic Neoplasms
8
Colorectal Neoplasms
6
Rectal Neoplasms
3
Stomach Neoplasms
2
Small Cell Lung Carcinoma
2
Sarcoma, Ewing
2
Rhabdomyosarcoma
2
Recurrence
2
Osteosarcoma
2
Neoplasms
2
Neoplasm Metastasis
2
Nasopharyngeal Carcinoma
2
Cholangiocarcinoma
2
Wilms Tumor
1
Small Cell Lung Cancer Extensive Stage
1
Small Bowel Adenocarcinoma
1
Sarcoma
1
Rhabdoid Tumor
1
Peritoneal Neoplasms
1
Pancreatic Ductal Adenocarcinoma
1
Pancreatic Cancer Metastatic to Liver
1
Neuroectodermal Tumors, Primitive, Peripheral
1
Neuroblastoma
1
Metastatic Gastric Adenocarcinoma
1
Malignant Ascites
1
Locally Advanced Rectal Cancer
1
Hepatoblastoma
1
Gastroesophageal Junction Adenocarcinoma
1
Colorectal Cancer Metastatic
1
Colonic Neoplasms
1
Interventions
Gemcitabine
5
Cisplatin
5
Oxaliplatin
3
tivozanib
2
durvalumab
2
zimberelimab
1
trametinib
1
tislelizumab
1
quemliclustat
1
pertuzumab
1
pembrolizumab
1
irinotecan sucrosofate
1
atezolizumab
1
anlotinib
1
Yttrium-90
1
Tissue Adhesives
1
Stents
1
Ritonavir
1
Radiosurgery
1
Radiofrequency Ablation
1
Positron Emission Tomography Computed Tomography
1
Photosensitizing Agents
1
Photochemotherapy
1
Pancreaticojejunostomy
1
Liver Transplantation
1
Leucovorin
1
Itraconazole
1
Fluorouracil
1
Floxuridine
1
FAPI-46
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Bile Duct Neoplasms
×
irinotecan sucrosofate
×
Clear all
NCT05277766
2025-07-01
PIPAC-NAL-IRI
University Hospital, Ghent
Phase 1
Recruiting
45 enrolled